IMARC Group has recently released a new research study titled “Canada Artificial Intelligence in Healthcare Market Size, Share, Trends and Forecast by Offering, Technology, Application, End User and Region, 2025-2033,” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
Canada Artificial Intelligence in Healthcare Market Overview
The Canada artificial intelligence in healthcare market size reached USD 163.80 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,321.44 Million by 2033, exhibiting a growth rate (CAGR) of 36.81% during 2025-2033.
Market Size and Growth
Base Year: 2024
Forecast Years: 2025-2033
Historical Years: 2019-2024
Market Size in 2024: USD 163.80 Million
Market Forecast in 2033: USD 3,321.44 Million
Market Growth Rate 2025-2033: 36.81%
Request for a sample copy of the report: https://www.imarcgroup.com/canada-artificial-intelligence-in-healthcare-market/requestsample
Key Market Highlights:
✔️ Rapid digital transformation across healthcare systems is accelerating AI adoption for diagnostics, treatment planning, and patient monitoring
✔️ Increasing government and private investments are supporting AI-driven medical innovations and research
✔️ Growing integration of machine learning in medical imaging, virtual care, and hospital workflow automation is improving clinical outcomes and operational efficiency
Canada Artificial Intelligence in Healthcare Market Trends
The Canada Artificial Intelligence in Healthcare Market is undergoing significant change, shaped by evolving regulations and growing demand for digital health solutions. The Artificial Intelligence and Data Act (AIDA) has set new standards, while concerns over health data privacy in 2024 led Health Canada to fast-track AI diagnostic approvals. This resulted in a 40% year-over-year increase in AI-assisted imaging.
Provincial initiatives, such as Ontario’s $120 million AI Health Fund, have encouraged collaboration between startups and hospital networks. Demand for AI-driven remote patient monitoring has also risen sharply—up 55% since 2024—driven by an aging population and persistent physician shortages. However, fragmented interprovincial data-sharing rules remain a challenge, limiting scalability and prompting hybrid cloud adoption. Ethical concerns, particularly around algorithmic bias in Indigenous healthcare, are expected to be a focal point in 2025.
Canada Artificial Intelligence in Healthcare Market Size and Key Segments
A major contributor to Canada Artificial Intelligence in Healthcare Market Size is precision oncology. In 2024, AI-based genomic tools captured 32% of total market share, supported by national projects like the Pan-Canadian Genome Library, which leverages federated learning to analyze more than 500,000 patient genomes while protecting privacy.
Pharmaceutical companies, including Roche, invested over $200 million into AI for drug discovery, with a focus on rare diseases affecting Canada’s diverse population. Real-world evidence platforms such as BlueDot are increasingly used to predict outbreaks, though data silos between academic and hospital research remain an obstacle. In rural areas, AI adoption continues to lag, with telehealth use at just 15% despite ongoing broadband expansion efforts.
Robotics, Administration, and Healthcare Efficiency
Surgical robotics is a growing area in the Canada Artificial Intelligence in Healthcare Market Report. In 2024, advances in haptic feedback and computer vision helped reduce cardiac intervention errors by 60% and shortened recovery times by 30%. AI is also streamlining healthcare administration by optimizing billing and scheduling processes, saving the sector an estimated $380 million annually. Voice-enabled AI tools are now assisting nurses with real-time documentation, improving workflow efficiency.
However, rising supply chain costs in 2024 pushed up robotics prices, slowing adoption among smaller healthcare facilities. Cybersecurity risks have also increased, with hospitals in Quebec experiencing high-profile cyberattacks that exposed vulnerabilities in AI-based systems. The ongoing shortage of domestic AI talent—driven by a 75% migration of developers to the U.S.—continues to strain innovation capacity.
The Canada Artificial Intelligence in Healthcare Market Trends highlight a growing shift from diagnostics to predictive care. AI tools are being used to forecast ICU bed shortages and predict complications related to chronic illnesses such as diabetes. Alberta’s $90 million investment into AI ethics research underscores the importance of responsible innovation, while federal efforts continue to fast-track approvals for AI radiology tools.
Cloud-based AI adoption increased 48% in 2024 as hospitals sought scalable, cost-effective solutions amid delays in robotic system rollouts caused by global chip shortages. Regulatory harmonization with EU and U.S. AI frameworks is creating opportunities for Canadian exports, though cross-border compliance and data sovereignty remain ongoing challenges.
Future Outlook
The Canada Artificial Intelligence in Healthcare Market Outlook points to continued expansion in 2025 and beyond. Decentralized clinical trials for rare diseases, Indigenous-led data governance initiatives, and stronger oversight for algorithmic fairness are expected to shape the next stage of growth. Despite issues around workforce shortages and cybersecurity, collaboration between government, academia, and industry is positioning Canada as a regional leader in healthcare AI innovation.
Canada Artificial Intelligence in Healthcare Market Segmentation:
The market report segments the market based on product type, distribution channel, and region:
Breakup by Offering:
- Hardware
- Software
- Services
Breakup by Technology:
- Machine Learning
- Context Aware Computing
- Natural Language Processing
- Others
Breakup by Application:
- Robot-Assisted Surgery
- Virtual Nursing Assistant
- Administrative Workflow Assistance
- Fraud Detection
- Dosage Error Reduction
- Clinical Trial Participant Identifier
- Preliminary Diagnosis
- Others
Breakup by End User:
- Healthcare Providers
- Pharmaceutical and Biotechnology Companies
- Patients
- Others
Breakup by Region:
- Ontario
- Quebec
- Alberta
- British Columbia
- Others
Competitive Landscape:
The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.
Key Highlights of the Report
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91-120-433-0800
United States: +1 201971-6302
